These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 33710277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants.
    Peters EN, Mosesova I, MacNair L, Vandrey R, Land MH, Ware MA, Turcotte C, Bonn-Miller MO.
    J Anal Toxicol; 2022 May 20; 46(5):528-539. PubMed ID: 33848338
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract.
    Nadulski T, Pragst F, Weinberg G, Roser P, Schnelle M, Fronk EM, Stadelmann AM.
    Ther Drug Monit; 2005 Dec 20; 27(6):799-810. PubMed ID: 16306858
    [Abstract] [Full Text] [Related]

  • 6. Safety and tolerability of escalating cannabinoid doses in healthy cats.
    Kulpa JE, Paulionis LJ, Eglit GM, Vaughn DM.
    J Feline Med Surg; 2021 Dec 20; 23(12):1162-1175. PubMed ID: 33769105
    [Abstract] [Full Text] [Related]

  • 7. A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History.
    Berl V, Hurd YL, Lipshutz BH, Roggen M, Mathur EJ, Evans M.
    Cannabis Cannabinoid Res; 2022 Dec 20; 7(6):777-789. PubMed ID: 35787693
    [Abstract] [Full Text] [Related]

  • 8. A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
    Taylor L, Gidal B, Blakey G, Tayo B, Morrison G.
    CNS Drugs; 2018 Nov 20; 32(11):1053-1067. PubMed ID: 30374683
    [Abstract] [Full Text] [Related]

  • 9. A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray.
    Stott CG, White L, Wright S, Wilbraham D, Guy GW.
    Eur J Clin Pharmacol; 2013 May 20; 69(5):1135-47. PubMed ID: 23179176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, Safety, and Tolerability of a Medicinal Cannabis Formulation in Patients with Chronic Non-cancer Pain on Long-Term High Dose Opioid Analgesia: A Pilot Study.
    Bonomo Y, Norman A, Collins L, O'Neill H, Galettis P, Trinca J, Strauss N, Martin J, Castle D.
    Pain Ther; 2022 Mar 20; 11(1):171-189. PubMed ID: 34921662
    [Abstract] [Full Text] [Related]

  • 13. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ, Spindle TR, Cone EJ, Goffi E, Kuntz D, Mitchell JM, Winecker RE, Bigelow GE, Flegel RR, Vandrey R.
    J Anal Toxicol; 2022 May 20; 46(5):494-503. PubMed ID: 34089060
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR, Vinckenbosch F, Kevin RC, Theunissen EL, McGregor IS, Ramaekers JG.
    JAMA; 2020 Dec 01; 324(21):2177-2186. PubMed ID: 33258890
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
    Liu Z, Galettis P, Broyd SJ, van Hell H, Greenwood LM, de Krey P, Steigler A, Zhu X, Schneider J, Solowij N, Martin JH.
    Intern Med J; 2020 Jul 01; 50(7):846-853. PubMed ID: 31264294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.